611 filings
Page 4 of 31
S-8
0oj2j gjluhoph1nzqn
21 Aug 23
Registration of securities for employees
4:06pm
8-K
zga3ddj
18 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
zawnljks 7so1
21 Jul 23
First Wave BioPharma, Inc. Announces Pricing of $2.1 Million Public Offering
8:19am
424B4
ipls2fowj rxylatvz55
20 Jul 23
Prospectus supplement with pricing info
5:26pm
EFFECT
hw4qqs5 l6o6las0qhid
18 Jul 23
Notice of effectiveness
12:15am
CORRESP
2u4ekmu1
14 Jul 23
Correspondence with SEC
12:00am
CORRESP
31x46d9nnpg8ewbo7
14 Jul 23
Correspondence with SEC
12:00am
CORRESP
svrxlopnngnhutuk
14 Jul 23
Correspondence with SEC
12:00am
CORRESP
mlje9xnffn8 8ye1l8
14 Jul 23
Correspondence with SEC
12:00am
8-K
jjxf9
13 Jul 23
First Wave BioPharma Announces Initial Topline Results from Phase 2 SPAN Clinical Trial Investigating Enhanced Adrulipase Formulation
12:00am
CORRESP
5wr1 zbw6qj9at6xp
13 Jul 23
Correspondence with SEC
12:00am
CORRESP
688cetyy6 dvr
13 Jul 23
Correspondence with SEC
12:00am
CORRESP
wpz036307sq 68emxx2
11 Jul 23
Correspondence with SEC
12:00am
4
i8zvq 5ep
5 Jul 23
First Wave BioPharma / Sarah Romano ownership change
4:28pm
4
3z0f1zls5srzt51b 2ad
5 Jul 23
First Wave BioPharma / JAMES SAPIRSTEIN ownership change
4:27pm
D
36qipb
28 Jun 23
$431.08 k in options, sold $431.08 k, 1 investor
4:05pm